Doppler-Echocardiographic Assessment of Tricuspid Regurgitation
Section snippets
Suitability for surgical or per-cutaneous repair
The indication for TR repair (surgical or per-cutaneous) should be determined by an interdisciplinary Heart Team. The following aspects need to be considered:
1) Clinical indication based on the current guidelines for treatment of valve disease.
2) Mechanism of TR.
3) TR severity.
4) Availability of echocardiographic imaging windows of sufficient quality to allow reliable per-cutaneous procedural success.
5) Right ventricular function.
6) The presence and severity of pulmonary artery hypertension.
7)
Conclusions
Mild TR is common in normal individuals. In patients with more than mild TR, identifying the severity, etiology and mechanism of TR is crucial. No single Doppler and echocardiographic measurement or parameter is precise enough to quantify TR severity thus integration of multiple parameters is required. If these parameters are discordant, then TR quantitation should be performed. Etiology of TR is extremely heterogeneous, and outcome of TR is dependent on etiology, thus etiology of TR should be
References (33)
- et al.
Impact of tricuspid regurgitation on long-term survival
J Am Coll Cardiol
(2004 Feb 4) - et al.
Clinical outcome of isolated tricuspid regurgitation
JACC Cardiovasc Imaging
(2014 Dec) - et al.
Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy
Am J Cardiol
(1998 Nov 15) - et al.
The international multicenter TriValve registry: which patients are undergoing transcatheter tricuspid repair?
JACC Cardiovasc Interv.
(2017) - et al.
First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve
J Am Coll Cardiol
(2015 Mar 31) - et al.
Recommendations for noninvasive evaluation of native valvular regurgitation: A report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance
J Am Soc Echocardiogr
(2017) - et al.
Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study
J Am Coll Cardiol
(2000 Aug) - et al.
Contrasting effect of similar effective regurgitant orifice area in mitral and tricuspid regurgitation: a quantitative Doppler echocardiographic study
J Am Soc Echocardiogr
(2002 Sep) - et al.
Effective regurgitant orifice area in tricuspid regurgitation: clinical implementation and follow-up study
Am Heart J
(1994 Nov) - et al.
Impact of implantable transvenous device lead location on severity of tricuspid regurgitation
J Am Soc Echocardiogr
(2014)
Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads
J Am Coll Cardiol
3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation
JACC Cardiovasc Imaging
Impact of right ventricular dysfunction and tricuspid regurgitation on outcomes in patients undergoing transcatheter aortic valve replacement
J Am Soc Echocardiogr
Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients
J Am Coll Cardiol
Multidetector row CT pulmonary angiography and indirect venography for the diagnosis of venous thromboembolic disease in intensive care unit patients
Acad Radiol
Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair?
Ann Thorac Surg
Cited by (8)
Tricuspid Regurgitation: From Imaging to Clinical Trials to Resolving the Unmet Need for Treatment
2024, JACC: Cardiovascular ImagingThe ultrasound revolution in cardiovascular diseases: A 50-year story from diagnosis to non-invasive treatment
2021, Archives des Maladies du Coeur et des Vaisseaux - PratiqueTricuspid Regurgitation: Disease State and Advances in Percutaneous Therapy
2023, European Cardiology ReviewMid-term outcomes of isolated tricuspid valve surgery according to preoperative clinical and functional staging
2022, European Journal of Cardio-thoracic SurgeryDeterminants of morbidity and mortality associated with isolated tricuspid valve surgery
2021, Journal of the American Heart Association
All authors have nothing to disclose.